Search research articles
Contact Us
Filters
Showing results (61-70 of 254) with videos related to
Page
of 26
Sort By:
Psychiatry Research
|
July 8, 2014
Metabolic syndrome and lung function in schizophrenia: a pilot study
Davy Vancampfort, Michel Probst, Brendon Stubbs, et al.
General Hospital Psychiatry
|
December 24, 2013
Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophrenia
Davy Vancampfort, Michel Probst, Brendon Stubbs, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
June 6, 2013
Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions
Gabriel Gerlinger, Marta Hauser, Marc De Hert, et al.
Revista De Psiquiatria Y Salud Mental
|
October 5, 2012
Cardiovascular disease and diabetes in people with severe mental illness
Marc De Hert, Jacqueline M Dekker, David Wood, et al.
Depression and Anxiety
|
March 28, 2013
Social anxiety in physical activity participation in patients with mental illness: a cross-sectional multicenter study
Amber De Herdt, Jan Knapen, Davy Vancampfort, et al.
Journal of Law and the Biosciences
|
October 21, 2022
Digital pills for the remote monitoring of medication intake: a stakeholder analysis and assessment of marketing approval and patent granting policies
Katerina Sideri, Julian Cockbain, Wim Van Biesen, et al.
Frontiers in Psychiatry
|
January 31, 2022
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review
Marc De Hert, Victor Mazereel, Marc Stroobants, et al.
International Clinical Psychopharmacology
|
August 31, 2011
The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs
Bruno Falissard, Mauro Mauri, Ken Shaw, et al.
CNS Drugs
|
August 21, 2012
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis
Marc De Hert, Weiping Yu, Johan Detraux, et al.
Schizophrenia Bulletin
|
December 31, 2011
Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis
Alex J Mitchell, Davy Vancampfort, Kim Sweers, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 254) with videos related to
Sort By:
Page
of 26
Psychiatry Research
|
July 8, 2014
Metabolic syndrome and lung function in schizophrenia: a pilot study
Davy Vancampfort, Michel Probst, Brendon Stubbs, et al.
General Hospital Psychiatry
|
December 24, 2013
Associations between expiratory spirometry parameters and limitations in daily life activities in patients with schizophrenia
Davy Vancampfort, Michel Probst, Brendon Stubbs, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
June 6, 2013
Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions
Gabriel Gerlinger, Marta Hauser, Marc De Hert, et al.
Revista De Psiquiatria Y Salud Mental
|
October 5, 2012
Cardiovascular disease and diabetes in people with severe mental illness
Marc De Hert, Jacqueline M Dekker, David Wood, et al.
Depression and Anxiety
|
March 28, 2013
Social anxiety in physical activity participation in patients with mental illness: a cross-sectional multicenter study
Amber De Herdt, Jan Knapen, Davy Vancampfort, et al.
Journal of Law and the Biosciences
|
October 21, 2022
Digital pills for the remote monitoring of medication intake: a stakeholder analysis and assessment of marketing approval and patent granting policies
Katerina Sideri, Julian Cockbain, Wim Van Biesen, et al.
Frontiers in Psychiatry
|
January 31, 2022
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review
Marc De Hert, Victor Mazereel, Marc Stroobants, et al.
International Clinical Psychopharmacology
|
August 31, 2011
The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs
Bruno Falissard, Mauro Mauri, Ken Shaw, et al.
CNS Drugs
|
August 21, 2012
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis
Marc De Hert, Weiping Yu, Johan Detraux, et al.
Schizophrenia Bulletin
|
December 31, 2011
Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis
Alex J Mitchell, Davy Vancampfort, Kim Sweers, et al.
Page
of 26